Bacterial pneumonia: Managing a deadly complication of influenza in older adults with comorbid disease

Geriatrics

Volumn 57, Issue 3, 2002, Pages 56-61

  Sethi, Sanjay ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFPODOXIME PROXETIL; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN; GATIFLOXACIN; INFLUENZA VACCINE; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; OSELTAMIVIR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIMANTADINE; SULTAMICILLIN; ZANAMIVIR;

AGED; BACTERIAL PNEUMONIA; CLINICAL FEATURE; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; HAEMOPHILUS INFLUENZAE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MORTALITY; OUTPATIENT; PATHOGENESIS; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

AGED; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PNEUMONIA, BACTERIAL; RISK FACTORS;

EID: 0036187182     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Trends in infectious disease mortality in the United States during the 20th century
2. The impact of influenza epidemics on hospitalizations
3. Pneumonia and influenza deaths during epidemics: Implications for prevention
4. Clinical course, management, and long-term sequelae of respiratory failure due to influenza viral pneumonia
5. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure
6. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease
7. Pulmonary defense mechanisms and the interaction between viruses and bacteria in acute respiratory infections
8. Respiratory viral infection predisposing for bacterial disease: A concise review
9. Interaction between viral and bacterial infections in the respiratory tract
10. The influence of bacterial superinfection on the clinical course of influenza: Studies from the influenza epidemics in Stockholm during the winters 1969-70 and 1971-72
11. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969
12. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities
13. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease
14. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older
15. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
16. Antiviral agents for treating influenza
17. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
18. Clinical signs and symptoms predicting influenza infection
19. Pulmonary antibacterial defenses during mild and severe influenza virus infection
20. A prediction rule to identify low-risk patients with community-acquired pneumonia
21. Guidelines for the management of adults with community-acquired pneumonia
22. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society
23. Practice guidelines for the management of community-acquired pneumonia in adults
24. Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters; 1997 U.S. Susceptibilities of Streptococcus pneumoniae, Surveillance Study
25. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
26. A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones
27. Quality of care, process, and outcomes in elderly patients with pneumonia
28. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network